Renin inhibitors in diabetes and hypertension: an update.

about

Renin inhibitors in diabetes and hypertension: an update.

Item

http://www.wikidata.org/entity/Q35728190

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Renin inhibitors in diabetes and hypertension: an update.

@ast

Renin inhibitors in diabetes and hypertension: an update.

@en

type

Item

label

Renin inhibitors in diabetes and hypertension: an update.

@ast

Renin inhibitors in diabetes and hypertension: an update.

@en

prefLabel

Renin inhibitors in diabetes and hypertension: an update.

@ast

Renin inhibitors in diabetes and hypertension: an update.

@en

P1476

Renin inhibitors in diabetes and hypertension: an update.

@en

P2093

Baran Ufuktepe

http://www.w3.org/2001/XMLSchema#string

Selcuk Sen

http://www.w3.org/2001/XMLSchema#string

Yagiz Üresin

http://www.w3.org/2001/XMLSchema#string

Zeynep Günes Özünal

http://www.w3.org/2001/XMLSchema#string

P2860

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Standards of medical care in diabetes--2014

Renin-Angiotensin-aldosterone system in diabetes and hypertension

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials.

The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.

Renin inhibition with aliskiren: where are we now, and where are we going?

The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.

P304

1111-1119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26417326

http://www.w3.org/2001/XMLSchema#string

P932

4464353

http://www.w3.org/2001/XMLSchema#string